Cancel
Known information
- Is a neuropsychologist
- Has over 18 years' experience working in clinical development in the pharmaceutical industry with a focus on pain and migraine
- Has held positions in both clinical operations and clinical strategy including leading multidisciplinary clinical teams at Roche, GSK, Convergence Pharmaceuticals, and Biogen
- Was a founding member of Convergence Pharmaceuticals Ltd and a member of the leadership team
- As the Head of Clinical Operations at Convergence, was responsible for designing and managing the full-service outsourcing of phase 1 and 2 clinical studies in pain
- Was also responsible for establishing and maintaining the Quality System
About Eliem Therapeutics
Eliem Therapeutics is a biopharmaceutical company focused on developing therapies for neuronal excitability disorders, with key projects including ETX-155 for major depressive disorder and focal onset seizures.
Report inaccurate information
